• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Low-Cost, Needle-Free and Non-Refrigerated Treatment for Postpartum Hemorrhage

This project will involve the development of a novel aerosol delivery system for oxytocin that can be inhaled by patients from a simple, disposable device immediately after childbirth. This approach will remove the need for sterile conditions and trained health workers for administration of oxytocin. It will eliminate the risk of needle-stick injuries, transmission of blood-borne viruses and the costs associated with disposal of sharps and biohazard waste materials, as well as provide a more stable formulation of the drug that does not require cold-chain storage. This project will lead to increased access to proven evidence-based strategies for the prevention and treatment of post-partum hemorrhage for women in remote, rural communities. The product will be low-cost and have an immediate, substantial impact on maternal mortality and is not dependent on material resources, electricity, clean water or transportation to hospitals.

More information about Saving Lives at Birth (Round 1)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.